# Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee

> **NCT01066676** · PHASE4 · COMPLETED · sponsor: **Gebro Pharma GmbH** · enrollment: 482 (actual)

## Conditions studied

- Osteoarthritis of the Hip or Knee

## Interventions

- **DRUG:** Dexibuprofen
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT01066676
- **Lead sponsor:** Gebro Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066676, "Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01066676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*